Escalon Medical Corp. announced earnings results for the second quarter ended December 31, 2019. For the second quarter, the company announced total revenue was USD 2.739 million compared to USD 2.418 million a year ago. Operating loss was USD 672,981 compared to USD 226,547 a year ago. Net loss was USD 675,343 compared to USD 217,983 a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.03 a year ago. For the half year, total revenue was USD 5.027 million compared to USD 4.677 million a year ago. Operating loss was USD 806,728 compared to USD 269,942 a year ago. Net loss was USD 53,970 compared to USD 265,719 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.04 a year ago.